Clinical Trial Update: The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters [NA]

View source ↗

Summary

Clinical trial evaluating a novel gonadotropin-releasing hormone (GnRH) antagonist with add-back therapy for uterine fibroids and endometriosis and its impact o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• GnRH antagonist with add-back therapy

Snippet

Sponsor: University Hospital, Geneva | Conditions: Uterine Fibroid | NA | Status: RECRUITING